BOCA RATON, Fla., Jan 29, 2009 -- Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHB) is proud to announce it has retained the law firm of Chastain & Etcheson, LLC, located in Lewistown, Illinois, to assist in the final certification process of its Integrated Hospital Potable Water Disinfection System.
Mr. Gene Chastain, of Chastain & Etcheson, stated, "We are very excited about working with Pure H2O and in assisting them to bring their product to the marketplace. There is a growing demand for clean water and it is our opinion that the company's product addresses that demand."

Chastain & Etcheson, LLC is a law firm based out of Lewistown, Illinois. Chastain & Etcheson, LLC has a history of helping corporations with mergers and acquisitions, buyouts, obtaining financing, and all other corporate issues.
Pure H2O recently completed all pre-certification testing of its innovative drinking water treatment system with outstanding results. Pure H2O is ready to complete final certification through the EPA's contractor, National Sanitation Foundation (NSF). Certification of this system is expected to be completed within this 1st quarter and has a high likelihood for success. Upon completion, the Company will begin its marketing and sales campaign. The Company intends to target hospitals, nursing homes and medical facilities in need of pathogen-free and chemical-free water.

The certification process includes completion of its manufacturing facility, located in Blairsville, GA, as well as the final certification process of its products. Upon certification, Chastain & Etcheson will assist Pure H20 with its intended $5,000,000 mezzanine financing program. These funds will place the Company in a position to employ skilled workers in all areas of expertise.
Mr. Joseph Doxey, President of Pure H2O, stated "This engagement with Chastain & Etcheson is timely as this firm has stayed in tune with the progress of the Company. In the eyes of management they bring to us the last piece of the puzzle for Pure H20 to complete the final phase of development. We will now be able to complete our certification, manufacturing facility and bring our potable disinfection products to market. We are making a pivotal turn from years of development to revenue generation."
The Company will be announcing its progress on a regular basis and will continue to keep its shareholders apprised through these final stages. Visit our web-site for updates and to view our production Video at www.pureh20biotech.com.

On August 22, 2008 the Company successfully obtained an award of $500,000 through arbitration on its prior judgment granted in the United States Bankruptcy Court, Western District of Kentucky. On July 31, 2007, the Company was awarded patent #7250111, and has two additional patents pending at this time that are under review with the U.S. Patent and Trademark Office, Washington, D.C. The Company as of this date has approximately 640 million outstanding common shares with a float of 42 million common shares. All of the common shares issued but not in the float are restricted shares issued to non-selling insiders.

The foregoing press release contains forward-looking statements that can be identified by such terminology as "expects," "potential," suggests," "may," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations regarding future research, development and/or commercial results could be affected by, among other things, uncertainties relating to the availability of future financing; unexpected regulatory delays or government regulation generally; the company's ability to obtain or maintain patent and other proprietary intellectual property protection; and completion in general. Forward-looking statements speak only as to the date they were made. The company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.